Advertisement
Bloomberg TV

Bristol Myers CEO on Covid Drug Trials, Acquisitions, Texas Plant

Nov.19 — Bristol Myers Squibb Chairman and Chief Executive Officer Giovanni Caforio discusses the clinical trials of the company’s Covid-19 treatments, acquisition strategy, and progress on the inspection of its Texas facility by U.S. regulators. He speaks on "Bloomberg Markets: The Close."

Advertisement